| abstract |
The present invention provides a novel compound of formula (I):n□nThe pharmaceutically acceptable salt thereof, and the pharmaceutical composition thereof, are suitable for treating diseases and diseases mediated by ROR γ. Also provided is a pharmaceutical composition comprising the novel compound of formula (I), and its use in the treatment of one or more inflammatory, metabolic, autoimmune and other diseases or conditions. |